Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis

NCT03835507 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: recombinant human erythropoietin(rhEPO)

Sponsor

Hanyang University Seoul Hospital